Cost-effectiveness analysis of Vaborem in Carbapenem-resistant Enterobacterales (CRE) -Klebsiella pneumoniae infections in Italy

BACKGROUND: Vaborem is a fixed dose combination of vaborbactam and meropenem with potent activity against target Carbapenem-resistant Enterobacterales (CRE) pathogens, optimally developed for Klebsiella pneumoniae carbapenemase (KPC). The study aims to evaluate the cost-effectiveness of Vaborem vers...

Descripción completa

Detalles Bibliográficos
Autores principales: Mennini, Francesco Saverio, Gori, Mario, Vlachaki, Ioanna, Fiorentino, Francesca, Malfa, Paola La, Urbinati, Duccio, Andreoni, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557067/
https://www.ncbi.nlm.nih.gov/pubmed/34716794
http://dx.doi.org/10.1186/s13561-021-00341-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557067/
https://www.ncbi.nlm.nih.gov/pubmed/34716794
http://dx.doi.org/10.1186/s13561-021-00341-z

Ejemplares similares